Selected article for: "acute sars cov respiratory syndrome coronavirus and long disease"

Author: Akter, Fariya; Araf, Yusha; Hosen, Mohammad Jakir
Title: Corticosteroids for COVID-19: worth it or not?
  • Cord-id: ib8124ad
  • Document date: 2021_10_13
  • ID: ib8124ad
    Snippet: Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in patients causing significant morbidity and mortality. To diminish systemic hyper inflammation, a few physicians and researchers have utilized corticosteroids. Corticosteroid implementation has increased after the publication of interim guidelines regarding corticosteroid use in COVID-19 patients by WHO, despite the remaining c
    Document: Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in patients causing significant morbidity and mortality. To diminish systemic hyper inflammation, a few physicians and researchers have utilized corticosteroids. Corticosteroid implementation has increased after the publication of interim guidelines regarding corticosteroid use in COVID-19 patients by WHO, despite the remaining controversies regarding long-term side effects and disease progression capability of corticosteroids. In different studies, the implementation of corticosteroids on COVID-19 patients revealed controversial results, which require further intensive research. This review will present the current outcomes and possibilities of using corticosteroids to treat COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • active site and acute ards respiratory distress syndrome: 1, 2
    • active site and acute respiratory distress: 1, 2, 3
    • active site and long period: 1
    • activity inhibit and acute ards respiratory distress syndrome: 1, 2
    • activity inhibit and acute ards respiratory distress syndrome develop: 1
    • activity inhibit and acute phase: 1
    • activity inhibit and acute respiratory distress: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and adequate management: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and long period: 1, 2
    • acute ards respiratory distress syndrome and long term effect: 1
    • acute phase and adequate management: 1
    • acute phase and long period: 1, 2, 3
    • acute phase and long term complication: 1, 2
    • acute phase and long term effect: 1, 2
    • acute respiratory distress and adequate management: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory distress and long period: 1, 2, 3, 4, 5, 6
    • acute respiratory distress and long term complication: 1, 2
    • acute respiratory distress and long term effect: 1